Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 753

2.

Rac-induced increase of phosphorylation of myosin regulatory light chain in HeLa cells.

Brzeska H, Szczepanowska J, Matsumura F, Korn ED.

Cell Motil Cytoskeleton. 2004 Jul;58(3):186-99.

PMID:
15146537
3.

Ezrin/moesin in motile Walker 256 carcinosarcoma cells: signal-dependent relocalization and role in migration.

Rossy J, Gutjahr MC, Blaser N, Schlicht D, Niggli V.

Exp Cell Res. 2007 Apr 1;313(6):1106-20. Epub 2007 Jan 10.

PMID:
17292355
4.

Endothelial Rho and Rho kinase regulate neutrophil migration via endothelial myosin light chain phosphorylation.

Saito H, Minamiya Y, Saito S, Ogawa J.

J Leukoc Biol. 2002 Oct;72(4):829-36.

PMID:
12377953
5.

RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.

Clements RT, Minnear FL, Singer HA, Keller RS, Vincent PA.

Am J Physiol Lung Cell Mol Physiol. 2005 Feb;288(2):L294-306. Epub 2004 Oct 8.

6.

Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.

Hopkins AM, Pineda AA, Winfree LM, Brown GT, Laukoetter MG, Nusrat A.

Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G806-17. Epub 2006 Nov 30.

7.

Thrombin-induced phosphorylation of the regulatory light chain of myosin II in cultured bovine corneal endothelial cells.

Satpathy M, Gallagher P, Lizotte-Waniewski M, Srinivas SP.

Exp Eye Res. 2004 Oct;79(4):477-86.

PMID:
15381032
8.

Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.

Sawada K, Morishige Ki, Tahara M, Ikebuchi Y, Kawagishi R, Tasaka K, Murata Y.

Gynecol Oncol. 2002 Dec;87(3):252-9.

PMID:
12468322
9.
10.

Proplatelet formation is regulated by the Rho/ROCK pathway.

Chang Y, Auradé F, Larbret F, Zhang Y, Le Couedic JP, Momeux L, Larghero J, Bertoglio J, Louache F, Cramer E, Vainchenker W, Debili N.

Blood. 2007 May 15;109(10):4229-36. Epub 2007 Jan 23.

11.

Inhibition of myosin light chain kinase by p21-activated kinase.

Sanders LC, Matsumura F, Bokoch GM, de Lanerolle P.

Science. 1999 Mar 26;283(5410):2083-5.

13.

Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction.

Gohla A, Schultz G, Offermanns S.

Circ Res. 2000 Aug 4;87(3):221-7.

14.

Mechanisms of sodium fluoride-induced endothelial cell barrier dysfunction: role of MLC phosphorylation.

Wang P, Verin AD, Birukova A, Gilbert-McClain LI, Jacobs K, Garcia JG.

Am J Physiol Lung Cell Mol Physiol. 2001 Dec;281(6):L1472-83.

15.

Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line.

Yanase M, Ikeda H, Ogata I, Matsui A, Noiri E, Tomiya T, Arai M, Inoue Y, Tejima K, Nagashima K, Nishikawa T, Shibata M, Ikebe M, Rojkind M, Fujiwara K.

Biochem Biophys Res Commun. 2003 May 30;305(2):223-8.

PMID:
12745062
16.

RhoA and rho kinase regulate the epithelial Na+/H+ exchanger NHE3. Role of myosin light chain phosphorylation.

Szászi K, Kurashima K, Kapus A, Paulsen A, Kaibuchi K, Grinstein S, Orlowski J.

J Biol Chem. 2000 Sep 15;275(37):28599-606.

17.

E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.

Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, Nishimura M, Dosaka-Akita H.

Cancer Res. 2005 Dec 1;65(23):10776-82.

18.

Role of RhoA and Rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction.

van Nieuw Amerongen GP, Vermeer MA, van Hinsbergh VW.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):E127-33.

20.

The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.

Lepley D, Paik JH, Hla T, Ferrer F.

Cancer Res. 2005 May 1;65(9):3788-95.

Supplemental Content

Support Center